AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇺🇬
DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE in Uganda
4 products registered with NDA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR +
LAMIVUDINE +
TENOFOVIR
DISOPROXIL
FUMARATE ORAL SOLID
ORDINARY
TABLETS | UNKNOWN-318378b2 | MACLEODS PHARMACEUTICA LS LTD | active | — |
| DOLUTEGRAVIR +
LAMIVUDINE +
TENOFOVIR
DISOPROXIL
FUMARATE ORAL SOLID
ORDINARY
TABLETS | UNKNOWN-0ed6f714 | MACLEODS PHARMACEUTICA LS LTD | active | — |
| DOLUTEGRAVIR +
LAMIVUDINE +
TENOFOVIR
DISOPROXIL
FUMARATE ORAL SOLID
ORDINARY TABLETS | UNKNOWN-75ed87f0 | MACLEODS PHARMACEUTICA LS LTD | active | — |
| DOLUTEGRAVIR +
LAMIVUDINE +
TENOFOVIR
DISOPROXIL
FUMARATE ORAL SOLID
ORDINARY TABLETS | UNKNOWN-587cd9f3 | MACLEODS PHARMACEUTICA LS LTD | active | — |
DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE — NDA Registration Details
NDA (Uganda) has 4 registered products containing DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE, of which 4 are currently active. Data is sourced directly from the official NDA drug register and refreshed daily.
Track DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.